Abstract
Amyloid precursor protein (APP) has been implicated in the pathogenesis of Alzheimer disease, and the accumulation of APP products ultimately leads to the familiar histopathological and clinical manifestations associated with this most common form of dementia. A protein that has been shown to promote APP accumulation is β-secretase (β-site APP cleaving enzyme 1, or BACE1), which is increased in the cerebrospinal fluid in those affected with Alzheimer disease. Through in vivo studies using APP transgenic mice, we demonstrated that decreasing the expression of BACE1 via lentiviral vector delivery of BACE1 siRNA has the potential for significantly reducing the cleavage of APP, accumulation of these products, and consequent neurodegeneration. As such, lentiviral-expressed siRNA against BACE1 is a therapeutic possibility in the treatment of Alzheimer disease. We detail the use of lentivirus-expressed siRNA as a method to ameliorate Alzheimer disease neuropathology in APP transgenic mice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brookmeyer, R., Johnson, E., Ziegler-Gram, K., and Arrighi, H. M. (2007) Forecasting the global burden of Alzheimer’s disease Alzheimer’s and Dementia 3, 186-91.
Hardy, J., and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease 12, 383-8.
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-7.
Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., and Games, D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer’s disease. J Neurosci 16, 5795-811.
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and Wong, P. C (2001) BACE1 is the major (beta)-secretase for generation of A(beta) peptides by neurons. Nat Neurosci 4, 233-4.
Selkoe, D. J., Yamazaki, T., Citron, M., Podlisny, M. B., Koo, E. H., Teplow, D. B., and Haass, C (1996) The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid {Beta}-Protein. Annals of the New York Academy of Sciences 777, 57-64.
Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., Freedman, S., Frigon, N. L., Games, D., Hu, K., Johnson-Wood, K., Kappenman, K. E., Kawabe, T. T., Kola, I., Kuehn, R., Lee, M., Liu, W., Motter, R., Nichols, N. F., Power, M., Robertson, D. W., Schenk, D., Schoor, M., Shopp, G. M., Shuck, M. E., Sinha, S., Svensson, K. A., Tatsuno, G., Tintrup, H., Wijsman, J., Wright, S., and McConlogue, L (2001) BACE knockout mice are healthy despite lacking the primary {beta}-secretase activity in brain: implications for Alzheimer’s disease therapeutics. Hum Mol Genet 10: 1317-24.
Shen, J., Bronson, R., Chen, D., Xia, W., Selkoe, D., and Tonegawa, S. (1997) Skeletal and CNS Defects in Presenilin-1-Deficient Mice. Cell 89, 629-39.
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., and Evin, G. (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease Annals of Neurology 51, 783-6.
Fukumoto, H., Cheung, B. S., Hyman, B. T., and Irizarry, M. C. (2002) {beta}-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease. Arch Neurol 59, 1381-9.
Zetterberg, H., Andreasson, U., Hansson, O., Wu, G., Sankaranarayanan, S., Andersson, M. E., Buchhave, P., Londos, E., Umek, R. M., Minthon, L., Simon, A. J., and Blennow, K. (2008) Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease. Arch Neurol 65, 1102-7.
Stewart, S. A., Dykxhoorn, D. M., Palliser, D., Mizuno, H., Yu, E. Y., An, D. S., Sabatini, D. M., Chen, I. S. Y., Hahn, W. C., Sharp, P. A., Weinberg, R. A., and Novina, C. D. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-7.
Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F. H., Verma, I. M., and Masliah, E. (2005) Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8, 1343-9.
Crittenden, J. R., Heidersbach, A., and McManus, M. T. (2007) Lentiviral Strategies for RNAi Knockdown of Neuronal Genes. In: Current Protocols in Neuroscience: John Wiley and Sons.
Rosenblad, C., and Lundberg, C. (2003) Cells of the Nervous System. In: Federico M, ed. Lentivirus Gene Engineering Protocols. Totowa, NJ: Humana Press; 299-307.
Franklin, K. B. J., and Paxinos, G. (2007) The Mouse Brain in Stereotaxic Coordinates. 3 ed: Academic Press.
Rockenstein, E., Mallory, M., Mante, M., Sisk, A., and Masliah, E. (2001) Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta Journal of Neuroscience Research 66, 573-82.
Marr, R. A., Rockenstein, E., Mukherjee, A., Kindy, M. S., Hersh, L. B., Gage, F. H., Verma, I. M., and Masliah, E. (2003) Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice J Neurosci 23, 1992-6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Peng, K.A., Masliah, E. (2010). Lentivirus-Expressed siRNA Vectors Against Alzheimer Disease. In: Federico, M. (eds) Lentivirus Gene Engineering Protocols. Methods in Molecular Biology, vol 614. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-533-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-60761-533-0_15
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-532-3
Online ISBN: 978-1-60761-533-0
eBook Packages: Springer Protocols